Leaving Community
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Blog
dkNET community events and announcements in June, 2018
Dear dkNET Community,
dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.
dkNET Announcements
dkNET team will attend American Diabetes Association (ADA) 78th Scientific Sessions during June 22-26, 2018 in Orlando, FL. Come meet us to learn what's new at dkNET if you are attending ADA!
Schedule and location:
- June 23-25, 2018, booth# 1176
- Sunday, June 24, 2018, 12:00 – 1:00 PM, Poster presentation at poster board# 2006-P. Our poster will be displayed during the entire meeting.
dkNET Updates:
- New resources added to dkNET
EPIMHC (SCR_016279) is a database of naturally processed MHC-restricted peptide ligands and epitopes for customized computational vaccinology.
PeMtb (SCR_016278) is a database for MHC antigenic peptide of Mycobacterium tuberculosis. It aims to make a comprehensive repository of synthetic antigenic peptides predicted from several MHC predication servers.
HLAsupE (SCR_016277)
is a database of HLA supertype-specific epitopes. It describes major histocompatibility complex (MHC) molecules that bind short peptides derived from endogenous or exogenous antigens and present them onto the surface of antigen-presenting cells (APCs) for T-cell receptor (TCR) recognition.
Events in June, 2018
June 2-5, 2018
Digestive Disease Week
Recognized as one of the top 50 medical meetings by HCEA, Digestive Disease Week® (DDW) is the world's largest gathering of physicians, researchers and industry in the fields of gastroenterolog
Location: Washington DC, USA
More information: http://www.ddw.org/home
June 3-7, 2018
66th ASMS Conference on Mass Spectrometry and Allied Topics
The conference program is coordinated by Richard A. Yost (VP Programs), University of Florida. The schedule begins on Sunday, June 3 with tutorial lectur
June 4-6, 2018
2nd International Symposium on Lipid Oxidation and Antioxidants
This meeting will be a great opportunity to discuss theoretical aspects of lipid oxidation as well as state-of-the-ar
lipid oxidation and antioxidants in six sessions covering
- antioxidant and lipid oxidation evaluation methods
- elucidation of lipid oxidation and antioxidant mechanisms
- lipid oxidation in multiphase and complex systems
- control of lipid oxidation
- protein and lipid co-oxidation
and
- nutritional and physiological effects of oxidized lipids and antioxidants.
Location: Graz, Austria
More information: https://veranstaltungen.gdch.de/tms/frontend/index.cfm?l=7710&sp_id=2
June 6, 2018
Free webinar "T1D Technology Trends: What's next?"
Join us for a free webinar on June 6 from 12-12:30 p.m. with Dr. Anastasia Albanese-O'Neil
More information: http://ow.ly/TouJ30kfTI1
June 21, 2018
NIDDK Meeting: Urology O'Brien External Expert Panel
Registration Deadline: June 15, 2018
Location: Bethesda, MD, USA
More information: https://www.niddk.nih.gov/news/meetings-workshops/2018/urology-obrien-external-expert-panel
June 22 - 26, 2018
American Diabetes Association 78th Scientific Sessions
*Meet dkNET team at ADA!
The Scientific Sessions offers researchers and health care professionals an amazing opportunity to share ideas and learn about the significant advances in diabetes research, treatment, and care. Over the course of five days, attendees will receive exclusive access to more than 2,800 original research presentations, take part in provocative and engaging exchanges with leading diabetes experts, and expand professional networks with nearly 13,000 professional attendees from around the world.
Location: Orlando, FL, USA
More information: https://professional.diabetes.org/meeting/scientific-sessions/78th-scientific-sessions
June 24-28, 2018
14th Annual Conference of the Metabolomics Society
The Metabolomics Society is an independent, non-profit organization, governed by a Board of Directors composed of dedicated members of the metabolomics community but ultimately responsive to its members. The Metabolomics Society's vision is to become the premier organization devoted to the development of metabolism-base
Location: Seattle, WA, USA
More information: http://www.metabolomics2018.org/
June 25-26, 2018
NIDDK Workshop: Chronic Kidney Diseases in Agricultural Communities
There has been a significant increase in the global burden of chronic kidney diseases of uncertain or non-traditional etiologies, primarily in agricultural communities. This condition has variously been referred to as chronic kidney disease of unknown (CKDu) or non-traditional etiology (CKDnt), chronic intersitital nephritis in agricultural communities (CINAC) and Mesoamerican nephropathy (MeN). Although the general presentation of this condition appears to be similar across affected regions, it remains unclear whether this condition represents one common disease or a syndrome of related ones that differ from affected region to region. A number of potential etiologies and pathophysiologi
Location: Bethesda, MD, USA
More information: https://www.niddk.nih.gov/news/meetings-workshops/2018/chronic-kidney-diseases-in-agricultural-communities-2018
June 25-29, 2018
2018 Data Science Innovation Lab: Mathematical Challenges of Single Cell Dynamics
The BD2K Training Coordinating Center is organizing an Innovation Lab to foster the development of new interdisciplina
Location: Riverhouse on the Deschutes, 3075 N Hwy 97, Bend, OR 97703, USA
More information: https://bigdatau.ini.usc.edu/innovationlab2018
Funding opportunities information and deadlines in June, 2018
June 1, 2018
Funding Opportunity Application Due Date: Integrated Islet Distribution Program (IIDP) Islet Award Initiative (IIDP-IAI)
The IIDP Islet Award Initiative is intended to advance research in human islet biology by facilitating the ability of researchers to access human islets for high impact and novel research studies. The number of IIDP Islet Awards funded under this initiative will be determined in any single year based on available resources. Application Due Date(s): Quarterly - Feb 1, June 1, October 1 of each calendar year.
More information: https://iidp.coh.org/Investigators/Islet-Award-Initiative
June 5, 2018
Funding Opportunity Application Deadline: High Priority HIV/AIDS Research within the Mission of the NIDDK
This Funding Opportunity Announcement (FOA) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that addresses high priority HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities are described in NOT-OD-15-13
More information: https://grants.nih.gov/grants/guide/pa-files/PAS-18-698.html
June 5, 2018
Funding Opportunity Application Due Date: New Directions in Hematology Research (SHINE-II) (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) is calling for R01 grant applications in nonmalignant hematology research. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Aging (NIA) have joined together to build and promote research activities in nonmalignant hematology. Innovative research project applications that will steer the field in new directions are invited. Each project will propose proof of principle research that is tightly focused into one specific aim and is directed at validating novel concepts and approaches that promise to open up new pathways for discovery. Research applications submitted under this FOA should be more limited in scope (a single central aim) and duration (1-3 years) than typical R01 grant applications.
June 9, 2018
NIH Common Fund Funding Opportunity Letter of Intent Due Date: Cutting Edge Informatics Tools for Illuminating the Druggable Genome (U01 Clinical Trial Not Allowed)
The overarching goal of this FOA is to add informatics capabilities to the Common Fund program, Illuminating the Druggable Genome IDG; https://coThe purpose of this specific FOA is to solicit applications to build a set of Cutting Edge Informatics Tools (CEITs) that will augment the capability of the KMC as well as the broader IDG Consortium in the following ways: (1) by developing and deploying tools to enhance the community's ability to process, analyze, and visualize IDG data, (2) to prioritize new data resources and methods to be incorporated into Pharos https://
June 10, 2018
NIDDK Funding Opportunity Letter of Intent Due Date: Elucidating the Effect of Glycemic Excursions on Patient Well-being and Cognitive Status in People with Type 1 Diabetes (T1D) (R01 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages applications from institutions/or
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-003.html
June 10, 2018
NIDDK Funding Opportunity Letter of Intent Due Date: Funding For Collaborative Clinical Research In Type 1 Diabetes: Living Biobank (R01 Clinical Trial Optional)This Funding Opportunity Announcement (FOA) invites applications for studies of etiology and pathogenesis related to development of type 1 diabetes (T1D) and/or its complications. Studies must involve subjects enrolled and followed in clinical trials, long term follow-up, or observational studies. This opportunity is intended to fund collaborative projects that bring new expertise and innovative approaches to enhance the value of major ongoing clinical research projects.
More information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-032.html
June 10, 2018
NIDDK Funding Opportunity Letter of Intent Due Date: Incorporating Patient-Reported Outcomes into Clinical Care for Type 1 Diabetes (R01 Clinical Trial Required)
This FOA will support research to test approaches in the healthcare setting to using Patient-Reporte
June 10, 2018
NIDDK Funding Opportunity Letter of Intent Due Date: Mass Spectrometric Assays for the Reliable and Reproducible Detection of Proteins/Peptides of Importance in Type 1 Diabetes Research (U01 Clinical Trial Not Allowed)
June 10, 2018
NIDDK Funding Opportunity Letter of Intent Due Date: Treating Diabetes Distress to Improve Glycemic Outcomes in Type 1 Diabetes (R01 Clinical Trial Required)
This FOA seeks applications for clinical trials testing interventions targeting diabetes distress in individuals with T1D and/or their caregivers, with the goal of understanding whether lowering diabetes distress will improve glycemic control and quality of life.June 11, 2018
Funding Opportunity Application Deadline: The 2018 DiaComp Conference Support Program
NIDDK-sponsJune 11, 2018
Funding Opportunity Application Due Date: DiaComp Pilot And Feasibility Program
This program solicits and funds small Pilot and Feasibility (P&F) projects in high impact areas of complications research. Specifically, this program aims to support discovery (hypothesis generating) and innovative (high risk/ high reward) research that is increasingly difficult to support through standard NIH mechanisms. Basic, translational and clinical research proposals are encouraged. Research involving human subjects is limited to observational studies with non-invasive or minimally invasive testing and must have IRB approval that includes the collection and use of human samples for research purposes. Interventional clinical trials are beyond the scope of this program. Awards are expected to prepare the applicant(s) to submit a future investigator initiated project (e.g. NIH R01). Lower priority will be given to applicants who have received DiaComp support in the past three years.June 11, 2018
Funding Opportunity Application Due Date: Food Specific Molecular Profiles and Biomarkers of Food and Nutrient Intake, and Dietary Exposure (R01 Clinical Trial Optional)
The purpose of this Funding Opportunity Announcement (FOA) is to promote research on food specific molecular signatures and biomarkers of dietary consumption and to promote collaborative interactions among NIH and the United States Department of Agriculture - National Institute on Food Safety (USDA-NIFA) supported nutrition researchers.June 16, 2018
Funding Opportunity Application Deadline: Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages research grant applications from institutions/orJune 16, 2018
Funding Opportunity Application Due Date: Secondary Analyses in Obesity, Diabetes and Digestive and Kidney Diseases (R21 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) encourages R21 applications that propose to conduct secondary analyses of existing data sets relevant to diabetes and selected endocrine and metabolic diseases including thyroid, parathyroid and Cushing’s diseases and acromegaly; and genetic metabolic disease including cystic fibrosis, lysosomal storage diseases, and disorders of the urea cycle, amino acid metabolism and metal transport where the focus is on peripheral metabolism or organ function; obesity, liver diseases, alimentary GI tract diseases and nutrition; kidney, urologic, and hematologic diseases. The goal of this program is to facilitate research that explores innovative hypotheses through the use of existing data sets or data, for which the primary goal is data analysis and not preparation/preJune 16, 2018
Funding Opportunity Letter of Intend and New Application Due Date: Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) encourages innovative research to enhance the quality of measurements of dietary intake and physical activity. Applications submitted to this FOA may include development of: novel assessment approaches; better methods to evaluate instruments; assessment tools for culturally diverse populations or various age groups, including children and older adults; improved technology or applications of existing technology; statistical methods/modelin
About
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant 2U24DK097771-09.
Recent News Entries
Contact Us
Email: info_at_ dknet.org
